Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,28,1.02 [0.91-1.14],0.705897881355102
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.27 [1.00-1.63],0.0546153969012606
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,22,1.12 [0.98-1.27],0.0875035516903564
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.28 [0.96-1.71],0.0935487887245284
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,41,1.01 [0.94-1.08],0.807279600885264
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.32 [0.40-4.35],0.652927491390191
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VWC2,Brorin,Inverse variance weighted,35,0.99 [0.89-1.11],0.897752426139506
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HSPB6,Heat shock protein beta-6,Inverse variance weighted,5,1.19 [0.72-1.95],0.499400008206827
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL17C,Interleukin-17C,Inverse variance weighted,8,1.08 [0.78-1.49],0.637415806511609
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,41,1.11 [0.97-1.27],0.120344619323598
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KLK13,Kallikrein-13,Inverse variance weighted,23,1.03 [0.93-1.14],0.54907425261546
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,4,0.89 [0.53-1.49],0.647901687437444
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,0.94 [0.66-1.34],0.725826416653722
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,F3,Tissue factor,Inverse variance weighted,26,1.23 [1.05-1.46],0.0130803777818131
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PRSS8,Prostasin,Inverse variance weighted,19,1.11 [0.85-1.45],0.436559630034863
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,AGRN,Agrin,Inverse variance weighted,31,0.94 [0.81-1.08],0.364856081205081
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.87 [0.79-0.96],0.0053373244405729
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SERPINB8,Serpin B8,Inverse variance weighted,29,0.98 [0.91-1.05],0.571127802868116
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD55,Complement decay-accelerating factor,Inverse variance weighted,27,1.01 [0.91-1.13],0.802649983590422
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.98 [0.90-1.07],0.623615239210081
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,REG1B,Lithostathine-1-beta,Inverse variance weighted,26,0.92 [0.82-1.04],0.195878201038179
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RBP2,Retinol-binding protein 2,Inverse variance weighted,6,1.80 [1.04-3.10],0.0342738916310696
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,22,0.93 [0.78-1.10],0.4014681560294
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,19,1.09 [0.88-1.35],0.416325827858279
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,1.13 [0.95-1.33],0.157007910042347
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DSC2,Desmocollin-2,Inverse variance weighted,16,1.03 [0.88-1.22],0.691403136907174
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLMP,CXADR-like membrane protein,Inverse variance weighted,15,0.87 [0.74-1.01],0.0716563233130169
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FOLR1,Folate receptor alpha,Inverse variance weighted,10,1.40 [1.06-1.84],0.01761575075133
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,20,1.00 [0.92-1.08],0.954383661088613
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,44,1.05 [0.98-1.12],0.186413623118193
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MMP12,Macrophage metalloelastase,Inverse variance weighted,21,1.08 [0.99-1.18],0.100989232155326
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.07 [0.68-1.68],0.761183632229903
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL27,C-C motif chemokine 27,Inverse variance weighted,12,1.04 [0.82-1.32],0.756603854912454
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,18,0.91 [0.72-1.16],0.450533207873678
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CAPG,Macrophage-capping protein,Inverse variance weighted,34,0.96 [0.87-1.06],0.386143213668734
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,30,0.93 [0.78-1.11],0.419769916326993
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MMP3,Stromelysin-1,Inverse variance weighted,35,0.92 [0.82-1.04],0.203982040669868
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,1.05 [0.75-1.48],0.759561643236564
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,1.13 [0.46-2.78],0.781802307447458
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RNASE4,Ribonuclease 4,Inverse variance weighted,13,0.81 [0.70-0.94],0.0066696214027459
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,62,1.05 [0.97-1.13],0.233731281655117
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,13,1.10 [0.76-1.60],0.599383785210846
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,22,0.98 [0.80-1.19],0.806660414254155
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL22,Interleukin-22,Inverse variance weighted,5,1.26 [0.71-2.22],0.425577866781777
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NPPC,C-type natriuretic peptide,Inverse variance weighted,5,1.10 [0.62-1.98],0.740378158609827
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,23,0.99 [0.90-1.10],0.890806997494207
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,35,1.03 [0.91-1.17],0.604007021613099
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,9,0.98 [0.63-1.51],0.927545313937885
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,0.98 [0.88-1.09],0.713164735396329
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,18,1.03 [0.89-1.19],0.733647047918109
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,8,1.25 [1.06-1.47],0.0090566372541761
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.85 [0.56-1.30],0.446604808943134
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,3,0.83 [0.49-1.43],0.506533287119524
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GPR158,Probable G-protein coupled receptor 158,Wald ratio,1,1.02 [0.43-2.41],0.972777804237854
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,0.98 [0.88-1.08],0.653906491773397
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,30,1.07 [0.93-1.23],0.369232683805023
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.63 [0.25-1.55],0.312199875718102
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,22,0.87 [0.74-1.03],0.102651486364519
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,S100P,Protein S100-P,Inverse variance weighted,8,0.81 [0.64-1.03],0.0820728158645278
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,31,1.01 [0.90-1.12],0.924558605270611
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,61,0.98 [0.92-1.04],0.441941384369067
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.94 [0.67-1.33],0.731310077543455
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,18,1.27 [1.10-1.47],0.0008865178687572
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RGMB,RGM domain family member B,Inverse variance weighted,10,1.00 [0.79-1.26],0.992445376071477
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,12,0.77 [0.58-1.01],0.0605612447705109
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,AREG,Amphiregulin,Inverse variance weighted,7,1.14 [0.82-1.58],0.427160743892548
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,13,0.92 [0.67-1.27],0.627896383322525
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,12,1.02 [0.72-1.43],0.924055268690781
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,1.05 [0.76-1.44],0.786993149841946
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,9,1.08 [0.86-1.37],0.502843391285436
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD83,CD83 antigen,Inverse variance weighted,19,0.96 [0.78-1.18],0.706060172676856
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,26,1.04 [0.92-1.17],0.56980249953929
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,0.82 [0.64-1.05],0.117376423773536
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,24,1.00 [0.86-1.15],0.957495109579225
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,11,1.06 [0.86-1.31],0.57335181742628
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KLK6,Kallikrein-6,Inverse variance weighted,6,1.11 [0.83-1.47],0.484203324998603
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.94 [0.66-1.36],0.757280401275861
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KLK8,Kallikrein-8,Inverse variance weighted,17,0.88 [0.75-1.02],0.0916673457175139
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD59,CD59 glycoprotein,Inverse variance weighted,8,1.11 [0.90-1.36],0.32110190939049
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,17,0.99 [0.84-1.16],0.868829556899528
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,0.86 [0.46-1.58],0.625138200601863
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADM,Pro-adrenomedullin,Inverse variance weighted,4,1.12 [0.86-1.46],0.393201289540536
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCN3,CCN family member 3,Inverse variance weighted,20,1.15 [0.98-1.35],0.0799631705032037
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MDK,Midkine,Inverse variance weighted,19,1.16 [0.93-1.45],0.178777771437583
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KLK4,Kallikrein-4,Inverse variance weighted,20,0.91 [0.81-1.03],0.129470355958394
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,1.15 [0.97-1.36],0.0990912630388079
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,2,1.07 [0.69-1.67],0.761092263038799
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LGALS9,Galectin-9,Inverse variance weighted,39,0.99 [0.87-1.13],0.904803190053847
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,15,1.00 [0.84-1.19],0.999415263269464
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SHISA5,Protein shisa-5,Inverse variance weighted,16,0.75 [0.53-1.06],0.106854867043457
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,11,0.96 [0.73-1.28],0.791259578069026
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,0.91 [0.63-1.31],0.602953673612456
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KLK11,Kallikrein-11,Inverse variance weighted,19,1.09 [0.98-1.21],0.130254517248115
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MMP7,Matrilysin,Inverse variance weighted,15,1.01 [0.88-1.16],0.861735573304206
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,12,0.92 [0.71-1.19],0.516044029787867
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,0.99 [0.73-1.36],0.974132892170472
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,16,0.99 [0.83-1.18],0.913674501052643
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.02 [0.66-1.57],0.927184401262644
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,42,1.00 [0.91-1.10],0.997468466394299
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,59,1.04 [0.95-1.14],0.408247471938533
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PENK,Proenkephalin-A,Inverse variance weighted,21,1.08 [0.94-1.24],0.292134523255476
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.97 [0.57-1.65],0.903561908238059
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,3,1.11 [0.46-2.65],0.814551016493891
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.47 [0.58-3.75],0.420633696532664
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.09 [0.91-1.31],0.362276683876417
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,0.96 [0.54-1.73],0.900826173862176
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RETN,Resistin,Inverse variance weighted,28,0.93 [0.84-1.03],0.157727514264092
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SEZ6L,Seizure 6-like protein,Inverse variance weighted,18,1.01 [0.84-1.21],0.898483159900434
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CA12,Carbonic anhydrase 12,Inverse variance weighted,20,0.95 [0.83-1.09],0.443433892169118
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GM2A,Ganglioside GM2 activator,Inverse variance weighted,26,1.10 [1.01-1.20],0.0288936968742936
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,23,0.89 [0.82-0.98],0.0122540835552844
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PGA4,Pepsin A-4,Inverse variance weighted,9,1.10 [0.76-1.58],0.618773823941696
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,0.95 [0.79-1.15],0.628180664130339
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PDCD1,Programmed cell death protein 1,Inverse variance weighted,24,1.04 [0.86-1.25],0.716182873264022
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CST3,Cystatin-C,Inverse variance weighted,13,1.00 [0.83-1.20],0.969483477484209
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.97 [0.91-1.04],0.408776747237229
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.81 [0.52-1.25],0.342986760520178
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,8,0.94 [0.74-1.20],0.642354085404099
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SDC1,Syndecan-1,Inverse variance weighted,14,1.12 [0.89-1.40],0.328675004500204
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TGFA,Protransforming growth factor alpha,Inverse variance weighted,11,1.01 [0.77-1.34],0.929178455250921
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.07 [0.85-1.34],0.562732527214343
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FBLN2,Fibulin-2,Inverse variance weighted,17,0.96 [0.83-1.11],0.581603358488198
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,6,1.00 [0.66-1.50],0.984541468242764
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,0.94 [0.83-1.06],0.310339184201267
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DTNB,Dystrobrevin beta,Inverse variance weighted,4,0.70 [0.35-1.41],0.321299506478542
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SCG2,Secretogranin-2,Inverse variance weighted,3,0.78 [0.43-1.41],0.418508679733671
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.00 [0.87-1.13],0.946238667395303
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,POF1B,Protein POF1B,Inverse variance weighted,4,0.84 [0.41-1.71],0.626591839151842
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,12,0.89 [0.74-1.07],0.205332921622374
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.01 [0.72-1.42],0.944109901826012
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DLL1,Delta-like protein 1,Inverse variance weighted,13,0.88 [0.70-1.11],0.281338953795825
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,24,1.08 [0.93-1.26],0.295691889560506
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ULBP2,UL16-binding protein 2,Inverse variance weighted,37,1.00 [0.93-1.07],0.9258174845987
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GAST,Gastrin,Inverse variance weighted,9,0.93 [0.69-1.26],0.660187365301434
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PYDC1,Pyrin domain-containing protein 1,Inverse variance weighted,72,1.00 [0.92-1.08],0.915915190031811
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,COLEC12,Collectin-12,Inverse variance weighted,13,0.88 [0.67-1.17],0.380728233778676
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ELN,Elastin,Inverse variance weighted,12,1.29 [0.88-1.90],0.185642600052297
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.27 [0.91-1.76],0.156061919906752
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,3,1.14 [0.45-2.86],0.784953459977176
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PRSS2,Trypsin-2,Inverse variance weighted,22,0.80 [0.64-1.00],0.0536089768900168
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,REN,Renin,Inverse variance weighted,12,1.02 [0.85-1.24],0.805051543148531
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,10,0.87 [0.70-1.09],0.218334125347925
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,32,1.03 [0.97-1.10],0.34858851471763
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,25,1.04 [0.91-1.19],0.540501147423901
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PI3,Elafin,Inverse variance weighted,20,0.99 [0.85-1.15],0.891108833261663
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,5,1.13 [0.71-1.82],0.604399121984883
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD160,CD160 antigen,Inverse variance weighted,36,1.07 [0.95-1.19],0.26049054040623
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,24,0.91 [0.80-1.04],0.183036584817792
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,9,1.05 [0.75-1.48],0.764875014065646
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,24,1.12 [0.99-1.27],0.0818213829990587
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CTSL,Cathepsin L1,Inverse variance weighted,29,0.97 [0.81-1.16],0.713089897274526
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,27,0.91 [0.78-1.05],0.191908139904053
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GUCA2A,Guanylin,Inverse variance weighted,16,0.90 [0.74-1.10],0.309918413183451
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,27,0.94 [0.88-1.00],0.0659807053948402
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,1.01 [0.78-1.32],0.917530661182809
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,Inverse variance weighted,4,0.96 [0.62-1.49],0.846104053501802
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,28,0.99 [0.91-1.07],0.709260902773899
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,24,1.00 [0.83-1.20],0.987464645683335
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.61 [0.30-1.24],0.17138590738513
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,15,1.01 [0.87-1.17],0.868160493766304
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,36,0.97 [0.87-1.08],0.597413636025119
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,S100G,Protein S100-G,Inverse variance weighted,4,0.91 [0.44-1.89],0.798132750851083
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HGF,Hepatocyte growth factor,Inverse variance weighted,7,0.88 [0.59-1.31],0.528292763624238
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,42,1.04 [0.95-1.15],0.388157034317061
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,11,1.26 [0.93-1.72],0.135512846544468
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.97 [0.87-1.08],0.602089773099874
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RBP7,Retinoid-binding protein 7,Inverse variance weighted,15,1.02 [0.87-1.20],0.782043371802292
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,13,1.08 [0.90-1.30],0.415829460042812
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,30,1.06 [0.94-1.18],0.341738143127353
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,1.11 [0.87-1.42],0.39984427267732
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LMNB2,Lamin-B2,Inverse variance weighted,9,0.99 [0.67-1.46],0.94034449290812
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CYTL1,Cytokine-like protein 1,Inverse variance weighted,10,1.01 [0.94-1.08],0.871316214884834
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,5,0.81 [0.60-1.09],0.156175345567739
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.97 [0.78-1.20],0.786230852198879
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.03 [0.69-1.54],0.891150565866469
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.74 [0.63-4.79],0.283892315477204
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LUZP2,Leucine zipper protein 2,Inverse variance weighted,9,1.03 [0.82-1.29],0.793631751725249
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FGF5,Fibroblast growth factor 5,Inverse variance weighted,43,1.02 [0.93-1.11],0.710403968006205
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,2,0.74 [0.42-1.31],0.303804510176842
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,54,1.07 [0.98-1.17],0.136314486292556
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,27,1.00 [0.92-1.09],0.919915386513764
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.07 [0.95-1.20],0.283244875262539
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SCG3,Secretogranin-3,Inverse variance weighted,48,0.95 [0.86-1.05],0.311097776781417
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.03 [0.93-1.13],0.61319347140161
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,17,1.05 [0.89-1.24],0.550508075230878
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PALM2,Paralemmin-2,Inverse variance weighted,9,1.02 [0.79-1.32],0.858707322273368
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DKK3,Dickkopf-related protein 3,Inverse variance weighted,28,1.04 [0.94-1.16],0.395385310110335
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,1.04 [0.81-1.33],0.755259978982005
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,1.16 [0.92-1.46],0.209549504305304
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PTN,Pleiotrophin,Inverse variance weighted,7,1.23 [0.78-1.94],0.37988411454553
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.94 [0.67-1.33],0.727291556583804
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.79 [0.56-1.12],0.182891601087873
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LGALS4,Galectin-4,Inverse variance weighted,19,0.95 [0.82-1.10],0.506879520019915
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,0.91 [0.70-1.18],0.471351343841161
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,18,0.91 [0.70-1.19],0.502462704953602
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EBI3_IL27,Interleukin-27,Inverse variance weighted,37,1.08 [0.97-1.21],0.17490878808786
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,0.35 [0.07-1.85],0.218380666622045
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,4,1.29 [0.88-1.91],0.190525825030784
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,23,1.00 [0.87-1.14],0.980454937938611
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NECTIN4,Nectin-4,Inverse variance weighted,12,0.93 [0.79-1.10],0.377367688076369
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CSTB,Cystatin-B,Inverse variance weighted,25,1.00 [0.88-1.13],0.956111457142335
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NUCB2,Nucleobindin-2,Inverse variance weighted,28,1.08 [0.95-1.22],0.26417434597731
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.06 [0.95-1.17],0.300415856258611
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Inverse variance weighted,5,1.17 [0.81-1.69],0.413661557010636
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,24,0.97 [0.82-1.14],0.679861506887878
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,0.88 [0.57-1.35],0.550347715929377
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.04 [0.67-1.60],0.877060700037633
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,0.99 [0.88-1.10],0.797349415867073
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CALB1,Calbindin,Inverse variance weighted,11,0.93 [0.69-1.24],0.60678384732608
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,0.82 [0.33-2.02],0.670734964419033
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD46,Membrane cofactor protein,Inverse variance weighted,3,1.05 [0.66-1.65],0.841868373479319
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.14 [0.92-1.41],0.222485619711181
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,20,1.08 [0.92-1.27],0.363248888777402
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,0.96 [0.56-1.66],0.89163780631506
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,0.92 [0.81-1.04],0.163259229298846
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,10,0.86 [0.70-1.07],0.175964455604402
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EFNA1,Ephrin-A1,Inverse variance weighted,15,1.07 [0.90-1.27],0.429148566890445
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,0.97 [0.81-1.17],0.758363579623545
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DPY30,Protein dpy-30 homolog,Inverse variance weighted,2,0.83 [0.36-1.94],0.669617196067444
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LPCAT2,Lysophosphatidylcholine acyltransferase 2,Inverse variance weighted,5,1.16 [0.86-1.56],0.331190375843251
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.20 [0.83-1.75],0.329092491324555
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,17,0.91 [0.80-1.04],0.15928942835367
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,0.95 [0.77-1.18],0.65234575162885
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,XG,Glycoprotein Xg,Inverse variance weighted,2,1.11 [0.19-6.47],0.905978180731288
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,36,1.07 [0.97-1.18],0.194110913506482
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,BSG,Basigin,Inverse variance weighted,8,1.11 [0.82-1.49],0.505604269374325
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,2,1.45 [0.67-3.16],0.343417345643827
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,21,0.93 [0.74-1.17],0.55869705204697
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.01 [0.84-1.22],0.892639405468045
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,INHBB,Inhibin beta B chain,Inverse variance weighted,16,1.15 [0.86-1.53],0.338179576158229
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,APOA2,Apolipoprotein A-II,Inverse variance weighted,16,1.07 [0.82-1.39],0.613146262582276
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,OCLN,Occludin,Inverse variance weighted,3,0.71 [0.36-1.39],0.320387886550698
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,0.99 [0.75-1.30],0.929188354511048
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CST6,Cystatin-M,Inverse variance weighted,32,1.06 [0.90-1.25],0.453457132288955
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SPON1,Spondin-1,Inverse variance weighted,25,0.99 [0.87-1.13],0.858459392286006
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL20,C-C motif chemokine 20,Inverse variance weighted,8,1.05 [0.76-1.45],0.761925529734914
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.08 [0.96-1.22],0.185737363845348
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,1.05 [0.75-1.47],0.771064303542295
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,25,0.99 [0.75-1.31],0.932341379110544
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RTBDN,Retbindin,Inverse variance weighted,5,0.89 [0.64-1.24],0.503947661131724
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.65 [1.04-2.60],0.0322735006212716
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PSAP,Prosaposin,Inverse variance weighted,13,0.88 [0.74-1.05],0.166006343235178
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,11,1.10 [0.93-1.30],0.260313769015421
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CX3CL1,Fractalkine,Inverse variance weighted,23,1.22 [1.01-1.48],0.0369653301568282
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ANGPT2,Angiopoietin-2,Inverse variance weighted,11,0.99 [0.76-1.29],0.927550136282218
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLEC3B,Tetranectin,Inverse variance weighted,9,0.97 [0.76-1.23],0.773091348626616
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SPP1,Osteopontin,Inverse variance weighted,19,1.08 [0.84-1.39],0.5272890590268
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,0.98 [0.73-1.31],0.876762638233426
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,0.96 [0.88-1.04],0.275742471112312
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PLIN3,Perilipin-3,Wald ratio,1,0.69 [0.33-1.47],0.341454440240082
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CFD,Complement factor D,Inverse variance weighted,12,0.99 [0.83-1.17],0.868227950658141
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,1.03 [0.85-1.26],0.759598790208818
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,24,0.83 [0.71-0.96],0.0128494524990903
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.05 [0.70-1.57],0.804735154017651
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,14,1.01 [0.79-1.29],0.934255640504924
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,18,0.92 [0.79-1.06],0.237911790122957
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,22,0.98 [0.85-1.12],0.716210132709072
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FGF23,Fibroblast growth factor 23,Inverse variance weighted,17,0.99 [0.75-1.30],0.95303561752057
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ANXA5,Annexin A5,Inverse variance weighted,2,0.96 [0.57-1.60],0.862933179940442
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,31,0.96 [0.90-1.03],0.306497919862672
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,22,1.05 [0.95-1.16],0.332946574183865
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LAYN,Layilin,Inverse variance weighted,23,1.03 [0.89-1.20],0.681610179423665
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.93 [0.78-1.11],0.428302828537723
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VGF,Neurosecretory protein VGF,Inverse variance weighted,2,1.40 [0.20-9.59],0.731052117263751
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.03 [0.64-1.66],0.894558236562016
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.89 [0.75-1.06],0.195694346720536
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,24,1.03 [0.91-1.18],0.619393413149015
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,34,0.98 [0.90-1.08],0.721743389338269
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,1.02 [0.63-1.65],0.925346559747344
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FABP6,Gastrotropin,Inverse variance weighted,5,1.31 [0.93-1.84],0.123201005470227
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,5,0.88 [0.37-2.10],0.771425381947956
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,23,0.87 [0.71-1.07],0.178522404754377
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.10 [0.97-1.25],0.12475390153077
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EFNA4,Ephrin-A4,Inverse variance weighted,5,0.66 [0.44-0.99],0.0421326451434073
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD276,CD276 antigen,Inverse variance weighted,47,1.00 [0.92-1.08],0.939327554241856
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SEPTIN8,Septin-8,Inverse variance weighted,6,1.41 [1.04-1.91],0.0282561105890179
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,1.13 [1.02-1.25],0.0223802968912936
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.13 [0.30-4.30],0.858763722493153
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,6,1.10 [0.69-1.75],0.694606354649521
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,0.80 [0.37-1.73],0.566749836359436
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL25,C-C motif chemokine 25,Inverse variance weighted,49,1.02 [0.95-1.10],0.533788272551915
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RNASET2,Ribonuclease T2,Inverse variance weighted,25,1.03 [0.89-1.18],0.706680120535907
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PALM,Paralemmin-1,Inverse variance weighted,10,0.97 [0.76-1.23],0.779465994139709
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD27,CD27 antigen,Inverse variance weighted,18,1.00 [0.86-1.16],0.968531652745039
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RSPO3,R-spondin-3,Inverse variance weighted,11,0.88 [0.69-1.12],0.288150828609587
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,0.99 [0.87-1.11],0.813128545995371
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,THBD,Thrombomodulin,Inverse variance weighted,16,1.15 [0.97-1.37],0.0972021350076941
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CHGB,Secretogranin-1,Inverse variance weighted,33,0.94 [0.86-1.03],0.160952506605453
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,1.00 [0.84-1.19],0.997946141388609
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.08 [0.93-1.27],0.320872886727827
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,AMBP,Protein AMBP,Inverse variance weighted,5,1.03 [0.63-1.70],0.896386732264402
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,22,0.95 [0.79-1.15],0.624455468730767
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,4,0.87 [0.65-1.17],0.355619279925936
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.88 [0.40-1.91],0.742317718501294
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD302,CD302 antigen,Inverse variance weighted,17,0.88 [0.75-1.02],0.0984759522482186
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,OGN,Mimecan,Inverse variance weighted,37,0.86 [0.76-0.96],0.0083538343265055
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,1.02 [0.86-1.22],0.789966365962251
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,75,0.93 [0.87-1.00],0.0384575373412826
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NECTIN2,Nectin-2,Inverse variance weighted,8,1.02 [0.87-1.19],0.816634959385614
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.10 [0.46-2.59],0.831584144041965
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GPR15L,Protein GPR15L,Inverse variance weighted,13,1.01 [0.86-1.19],0.875640527066139
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CDH1,Cadherin-1,Inverse variance weighted,17,0.98 [0.79-1.22],0.873211439992136
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PRELP,Prolargin,Inverse variance weighted,14,1.08 [0.92-1.26],0.35537119823603
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,1.10 [0.76-1.61],0.614767917378674
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PCDH7,Protocadherin-7,Inverse variance weighted,6,0.85 [0.59-1.22],0.375347415545166
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,8,1.02 [0.78-1.33],0.889324399615761
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,11,1.00 [0.80-1.26],0.973192131759707
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,35,0.99 [0.91-1.07],0.720943660114771
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SEMA3F,Semaphorin-3F,Inverse variance weighted,46,1.06 [0.90-1.24],0.493847617700613
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,43,0.92 [0.85-0.99],0.0318588543603162
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.08 [0.92-1.25],0.342964125631046
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,UMOD,Uromodulin,Inverse variance weighted,62,1.05 [0.99-1.12],0.122262623038208
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.04 [0.86-1.26],0.677060912961842
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD99,CD99 antigen,Inverse variance weighted,4,1.61 [0.94-2.76],0.0855907597812499
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,0.92 [0.62-1.37],0.678106045835816
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.02 [0.74-1.43],0.88696172135227
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DPT,Dermatopontin,Inverse variance weighted,26,0.89 [0.77-1.03],0.125491353580715
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.02 [0.83-1.25],0.836970770891013
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,23,0.97 [0.83-1.14],0.724682415141308
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ITGAV,Integrin alpha-V,Inverse variance weighted,14,0.99 [0.73-1.35],0.944556118839818
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,15,1.01 [0.93-1.10],0.773750184349648
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CDH3,Cadherin-3,Inverse variance weighted,12,0.93 [0.70-1.24],0.637434128045535
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SPON2,Spondin-2,Inverse variance weighted,8,0.88 [0.72-1.08],0.232891786443644
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,10,1.16 [0.83-1.64],0.385446317851369
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RNASE6,Ribonuclease K6,Inverse variance weighted,20,1.04 [0.92-1.17],0.523942192614667
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.76 [1.09-2.85],0.0219115204629856
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PGF,Placenta growth factor,Inverse variance weighted,8,0.76 [0.41-1.37],0.358385555958247
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.12 [0.88-1.42],0.357870561296757
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,17,0.85 [0.73-0.98],0.0278941858568547
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.88 [0.64-1.21],0.428025850841582
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.07 [0.81-1.42],0.620083616212453
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CHGA,Chromogranin-A,Inverse variance weighted,8,0.99 [0.79-1.24],0.930339343780517
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.83 [0.67-1.03],0.0879251329067559
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.99 [0.91-1.09],0.874967374571153
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,16,0.95 [0.78-1.16],0.620783156776913
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL19,Interleukin-19,Inverse variance weighted,21,1.05 [0.93-1.17],0.441831739286156
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,41,0.98 [0.91-1.06],0.669743658363298
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,8,0.79 [0.60-1.03],0.0781161839464841
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,WNT9A,Protein Wnt-9a,Inverse variance weighted,7,0.99 [0.72-1.34],0.931078445445497
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FAM3C,Protein FAM3C,Inverse variance weighted,5,1.17 [0.71-1.92],0.533794562307293
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LGALS1,Galectin-1,Inverse variance weighted,7,1.00 [0.85-1.18],0.969924372006579
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,30,0.86 [0.74-0.99],0.0343196002015331
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,38,1.01 [0.94-1.10],0.737889260502456
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,18,0.91 [0.77-1.07],0.253419785320018
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,29,1.03 [0.92-1.16],0.575277240582215
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,1.02 [0.86-1.20],0.829999937505168
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCN4,CCN family member 4,Inverse variance weighted,40,1.03 [0.94-1.13],0.577988435309851
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,6,1.13 [0.85-1.50],0.394673687267073
